Hereto, platelets were treated with P2Y12 inhibitor cangrelor or cyclo-oxygenase 1 inhibitor indomethacin to mimic platelet disorders, followed by stimulation with either CRP-XL or NbD2 tetramers. This evidence concerns the gene CRP and blood platelet disease.